After initial endoscopic evaluation, medication either with mosapride 5 mg tid or teprenone 50 mg tid was started. Severity and frequency of GSS and EPS, health-related quality of life (HR-QOL ...
The remaining 618 patients with symptoms of dyspepsia were randomized to receive pharmacotherapy by either mosapride (311 patients) or teprenone (307 patients) (Fig. 2). There were no significant ...